Farré · BMC medicine 2025 · longitudinal cohort study · n=171

VEGFA sex-specific signature is associated to long COVID symptom persistence.

Cited 4 times in the scientific literature.

Level 3 - non-randomized controlled study

Longitudinal non-randomized cohort study comparing proteomic profiles across two time points

PubMed 41074076 · doi:10.1186/s12916-025-04402-6 · record verified 2026-08-27

What was done

Researchers conducted proteomic profiling of 1395 protein biomarkers using Olink technology across two time points in 171 individuals with confirmed SARS-CoV-2 infection (including 133 long COVID patients) from the COVICAT cohort. Linear mixed models, gene set enrichment analysis, and protein-protein interaction networks were used to assess changes across long COVID status, sex, and hormonal status.

What was found

VEGFA was significantly overexpressed in long COVID patients (effect size 0.322, SE = 0.098, p = 0.0013) and had the highest centrality in a network of 109 nodes and 274 edges. VEGFA was significantly overexpressed specifically in postmenopausal women (Mann-Whitney U test p = 8.55 x 10^-3). Dysregulated chemokine signaling, complement activation, and viral reactivation were also confirmed.

Why it matters

This study links vascular dysfunction through VEGFA upregulation to long COVID persistence and identifies sex- and hormone-specific proteomic patterns that may clarify differing recovery trajectories.

Limits

The sample size is limited to 171 individuals, and exact timing of post-infection visits or symptom severities are not fully specified in the abstract. As an observational study, it identifies associations rather than direct causation.

Cited by